Advertisements

Velorin 100

Quick links to important sections

Velorin 100

Selected form

Advertisements

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Advertisements

Overview of Velorin 100

Quick Facts

Property Description
Active ingredient Atenolol
Form Tablet (Oral solid dosage form)
Pharmacological class Cardioselective beta-blocker
General purpose To reduce cardiac workload and manage systemic pressure
Origin Synthetic compound

What is the Identity and Therapeutic Class of Velorin 100?

Velorin 100 is a prescription-only medication whose active component is the synthetic substance Atenolol. This drug belongs to the class of medicines known as beta-blockers (specifically, beta-adrenoceptor blocking agents).

Its classification defines its function within the cardiovascular system, where it moderates the body’s response to stimulating hormones like adrenaline. Atenolol is designated as a cardioselective beta-blocker, a property clinically recognized for providing a more targeted effect primarily on the heart compared to older, non-selective alternatives. The key patient takeaway is that this medicine works by slowing the heart down and reducing the effort required to pump blood.

Composition, Origin, and Pharmaceutical Form

The core of Velorin 100 is the active ingredient, Atenolol, which is a synthetic compound derived through chemical synthesis. Atenolol is available as a tablet to be taken by mouth, confirming its intended oral route of administration for routine chronic management.

The numerical designation of 100 in the name Velorin 100 is a critical identifier that specifies the exact strength of Atenolol contained within each individual tablet. This single-ingredient preparation is manufactured using various solid pharmaceutical excipients necessary to form the stable oral dosage unit, suitable for adult patients requiring sustained therapeutic action.

General Purpose of this beta-Blocker

The general purpose of Velorin 100 is to promote a systematic and sustained reduction in cardiac workload and sympathetic nervous system influence on the heart. It achieves this by selectively preventing stimulating hormones from binding to receptors on the heart muscle.

Its mechanism of action allows it to inhibit the chronotropic and inotropic effects on the heart, leading to a decreased blood pressure. This confirms the fundamental general objective of the drug, which is to help the heart beat slower and with less force to manage conditions associated with excessive strain on the circulatory network.

Regulatory References

  1. NIH National Library of Medicine, LiverTox
  2. MedlinePlus
  3. NIH, StatPearls
Advertisements

What side effects are possible with Velorin 100?

Possible Side Effects and Safety Information

The following safety information for Velorin 100 (Atenolol) reflects the adverse reactions and constraints documented in official government regulatory labeling.


Adverse Reactions by Frequency

Adverse reactions are classified by frequency, ranging from common to rare, as documented in official regulatory sources.

  • Common Reactions (Affecting up to 1 in 10 users): These generally include bradycardia (slowed heart rate), a feeling of fatigue, and cold extremities (hands and feet). Gastrointestinal disturbances are also listed as common.
  • Uncommon Reactions (Affecting up to 1 in 100 users): Sleep disturbances, including nightmares, and documented elevations of transaminase levels (indicating effects on liver function) fall into this category.
  • Rare Reactions (Affecting up to 1 in 1,000 users): These include reactions across multiple organ systems such as dizziness, headache, and paraesthesia (nervous system); mood changes, confusion, and hallucinations (psychiatric); bronchospasm (respiratory); and impotence (reproductive).

Serious Safety Restrictions and Constraints

Official labeling defines situations where the use of Velorin 100 is strictly contraindicated due to the risk of serious adverse reactions. The medicine is prohibited in patients with Cardiogenic Shock, Overt Cardiac Failure, Sinus Bradycardia, or Heart Block greater than first degree.

The drug is associated with a risk of deterioration of heart failure and the potential for exacerbation of angina or myocardial infarction (heart attack) if treatment is discontinued abruptly. This mandates a gradual withdrawal process. Special safety considerations are noted for patients with renal impairment, as clearance is slower, and for diabetic patients, as the medication may mask certain signs of acute hypoglycemia.

Advertisements

Overdose and Emergency Response

Overdose and when to seek help

Overdose of Velorin 100 (Atenolol) is associated with documented severe physiological effects requiring urgent intervention. Officially listed manifestations include distinct signs of cardiovascular depression, such as bradycardia (abnormally slow heart rate) and sinus pause. Other documented symptoms are lethargy, wheezing, and a disorder of respiratory drive.

The regulatory profile details severe, potentially life-threatening systemic outcomes, including profound hypotension, acute congestive heart failure, bronchospasm, and a drop in blood sugar known as hypoglycemia.

Due to the critical nature of these documented adverse events, official guidance mandates seeking immediate professional medical attention for any known or suspected overexposure. Emergency services must be contacted immediately if severe signs, such as collapse, seizure, trouble breathing, or inability to be awakened, are present.

Overdose management procedures are directed toward supportive treatment and reducing the systemic drug burden. These measures include physical removal of unabsorbed drug through procedures such as gastric lavage, induced emesis, or the administration of activated charcoal. Furthermore, the drug can be removed from the general circulation by hemodialysis. Regulatory documents note that the drug's elimination route means the half-life may be increased in patients with severe renal impairment.

Advertisements

Therapeutic Uses of Velorin 100

What Velorin 100 Treats: Main Uses and Benefits

Velorin 100 (Atenolol) may be part of symptomatic management to help with symptoms related to heightened physiological activity and systemic imbalance.

The medication is used in situations involving certain distressing symptoms, including chronic high blood pressure (hypertension), recurrent chest discomfort (angina pectoris), and for long-term supportive care after a major cardiac event. It is also commonly used to help with symptoms related to conditions like thyrotoxicosis and may assist with managing the frequency of migraine headaches.

Velorin 100 is primarily used for the long-term management of essential hypertension, a condition characterized by sustained elevation in systemic pressure. Its use helps manage the symptoms of excessive systemic pressure, which contributes to easing the overall symptom load. This supports a patient's overall well-being and supports patients during difficult episodes by easing distress.

The application is applied in addressing recurrent chest discomfort that occurs with physical effort. This supports the management of symptoms related to heightened physiological activity. The use of this medication may assist with maintaining functional stability by easing the overall symptom load related to recurrent discomfort.

Quick Fact: Symptom Management for Angina Pectoris
Supports patients by easing the overall symptom load associated with recurrent physical discomfort.

Regulatory References

  1. NIH MedlinePlus Drug Information
Advertisements

Eligibility and Restrictions for Use

Who Can and Cannot Use Velorin 100?

Eligibility for Velorin 100 (Atenolol) is strictly determined by official regulatory documents, which define absolute prohibitions and populations requiring conditional use. The medicine is approved for use in adult patients for its indicated conditions.

Absolute Contraindications

Official labeling prohibits use in patients with certain high-risk conditions, including:

  • Second- or third-degree heart block
  • Marked sinus bradycardia (severe slow heart rate)
  • Cardiogenic shock or uncontrolled cardiac failure
  • Severe asthma or severe COPD
  • Untreated phaeochromocytoma or metabolic acidosis
  • Known hypersensitivity to Atenolol.

Populations Requiring Restrictions

Population Regulatory Status
Pediatric Use Not established; use is not recommended in children under 18.
Renal Impairment Conditional use; dose adjustment is required for patients with defined severe kidney impairment.
Pregnancy/Lactation Restricted use; should only be used if benefit justifies risk; caution advised during breastfeeding.
Older Adults Use requires caution; a lower starting dose may be necessary due to renal function changes.
Advertisements

What should I know about interactions with other medicines?

Officially Documented Combination Restrictions

Regulatory information classifies several combinations with Velorin 100 (Atenolol) as requiring strict restriction or separation. The co-administration of Sultopride and Monoamineoxidase Inhibitors (MAOIs), excluding selective MAO-B inhibitors, is documented as contraindicated due to risks such as ventricular arrhythmias and hypertensive crisis. The use of Verapamil or Diltiazem is prohibited in patients with pre-existing cardiac conduction abnormalities.

Pharmacodynamic and Absorption Effects

Velorin 100 demonstrates pharmacodynamic reinforcement when used alongside other cardiovascular agents. Co-administration with Digitalis glycosides (e.g., Digoxin) or Amiodarone may result in an additive depressant effect on heart rate and conduction. Conversely, Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), such as Indomethacin, are associated with a reduction in Atenolol’s hypotensive effect (antagonism).

Substances that interfere with absorption, such as Aluminum Hydroxide and Multivitamin with Minerals, must be separated by at least 2 hours to avoid reduced systemic exposure.

Sequence-Based and Condition Constraints

Co-administration with antidiabetic agents may intensify blood sugar lowering effects and can officially mask the symptom of tachycardia related to hypoglycemia. A specific sequence-based constraint dictates that Velorin 100 must be withdrawn several days before the gradual cessation of Clonidine to mitigate the risk of rebound hypertension. Furthermore, the official label notes that significant accumulation occurs in patients with renal impairment when creatinine clearance is low.

Advertisements

Mechanism of Action

Velorin 100 is a cardioselective beta-adrenergic receptor antagonist that primarily modulates signaling within the sympathetic nervous system. Its mechanism involves specific engagement with biological targets to influence key physiological pathways.

Selective Beta-1 Adrenergic Receptor Antagonism

Velorin 100 acts within domains involving receptor-mediated signaling by selectively binding to beta1-adrenergic receptors, which are highly expressed in cardiac tissue. This antagonism prevents the binding of endogenous catecholamines, thereby suppressing beta1-receptor activation via sympathetic stimuli.

Modulation of Cardiac Signal Transduction

This drug modifies early molecular steps by inhibiting the beta1-receptor-mediated signaling cascade. Blocking this pathway reduces adenylyl cyclase activity and its downstream effects. The resulting physiological effect includes the modification of chronotropic and inotropic state, decreasing the rate of cardiac depolarization and force generation.

Influence on Renin-Angiotensin System Pathways

Velorin 100 engages mechanisms that influence feedback regulation within pathways by inhibiting the release of renin from the juxtaglomerular cells in the kidneys. This action modifies signaling sequences impacting the renin-angiotensin-aldosterone system (RAAS), which influences systemic hemodynamics and vascular tone.

Advertisements

Dosage and Administration Information

How to Use Velorin 100 — Official Administration Guidelines

Velorin 100, which contains the active ingredient Atenolol, is administered according to a structured protocol detailed in prescribing information. The medicine is primarily taken orally via a tablet for chronic conditions like hypertension. However, an intravenous (IV) injection is specified for the initial, acute phase of certain cardiac events, such as a myocardial infarction, and must be administered in a hospital setting.


Dosing and Administration Schedule

Usage Parameter Official Administration Instructions
Standard Oral Frequency Primarily once daily (QD), regardless of meals, for maintenance therapy.
Initial Dose Typically 50 mg once daily. Titration, or dose increase, is only performed after a one-week period at the current dose to assess response.
Maximum Dose 100 mg daily for hypertension; up to 200 mg daily may be used for specific angina regimens.

Procedural Constraints and Adjustments

Administration requires consideration of specific conditions and adjustments based on the patient's physiological status. Treatment cessation must follow a gradual reduction schedule, where the daily dose is lowered over a period of seven to fourteen days; abrupt discontinuation is not permitted. This mandates a tapering protocol for the end of therapy.

For patients with impaired renal function, the maximum daily dose must be reduced significantly, with limits applied based on specific creatinine clearance levels. For instance, the maximum is 50 mg daily when creatinine clearance is between 15-35 mL/min. If a dose is missed, it is instructed to take the dose as soon as remembered, but to skip the dose if it is near the next scheduled time, without taking a double quantity.

Advertisements

Recent Clinical Evidence

Research Evidence / Overview of Studies for Velorin 100

Evidence for Chronic High Blood Pressure (Essential Hypertension)

Research examining Velorin 100 for the management of sustained high blood pressure relies primarily on large-scale Randomized Controlled Trials (RCTs) and comprehensive Meta-analyses. These studies explored how the compound's use relates to blood pressure metrics and monitored outcomes such as major cardiovascular events, including stroke or myocardial infarction, over defined follow-up periods. Studies consistently reported measurements showing observed changes in blood pressure levels across the patient groups. However, certain meta-analyses suggest that while the compound may be associated with blood pressure metrics, findings described varying patterns in the reported outcomes when contrasted with newer therapeutic options.

Evidence for Recurrent Chest Discomfort (Angina Pectoris)

Research related to Velorin 100 for recurrent chest discomfort was based on Controlled Therapeutic Trials. Studies explored outcomes related to physical discomfort by monitoring heart rate and evaluating metrics such as the patient's exercise tolerance. Findings describe patterns observed where individuals reported changes in the frequency of their discomfort episodes. The evidence base related to physical discomfort appears to be consistent across these trials, though follow-up durations were often limited for characterizing long-term impact on overall survival.

Areas of Research Uncertainty and Study Gaps

The research provides context about the current evidence landscape—and what is still uncertain. Findings were mixed or non-conclusive in comparative studies regarding patterns of outcomes against certain newer drug classes in tracking major long-term cardiovascular events. For post-heart attack supportive care, research describes patterns observed within specific patient groups, such as those categorized by their heart function; the extent of observation in patients with preserved function is still uncertain. Data for certain groups remain insufficient, and overall, there is limited information for long-term outcomes that fully characterizes the compound's observed properties.

Key Studies & References

  1. Atenolol Drug Information: Official Monograph and Therapeutic Uses
  2. Atenolol: StatPearls [Internet] - Comprehensive Overview of Indications and Pharmacology
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Velorin 100 (FAQ)

Q: How quickly should I expect to feel the effects of Velorin 100?

Official product information indicates that an effect on the heart rate can begin within one hour after taking an oral tablet. The maximum effect is usually seen in about 2 to 4 hours. However, the full benefit for managing chronic conditions like high blood pressure may take approximately 1 to 2 weeks of continuous therapy to be observed.

Q: What is the longest time Velorin 100 stays in your system?

In patients with normal kidney function, the drug's elimination half-life is approximately 6 hours, but its therapeutic effects on the heart and blood pressure are expected to last for about 24 hours from a single dose. Regulatory warnings note that Velorin 100 can accumulate in the body, particularly with kidney impairment. This may result in a longer period required for the drug to be fully cleared from the system.

Q: Does Velorin 100 usually cause drowsiness or make you tired?

Yes, regulatory documents list feelings of fatigue and tiredness as common side effects associated with this medication. While drowsiness (a feeling of sleepiness) is less common, it has also been reported in clinical experiences.

Q: Is it normal to have a slight headache when starting Velorin 100?

In official clinical data, headache has been reported as an adverse reaction. While some effects may be more noticeable when first starting a new medicine, headache is classified as a rare side effect according to regulatory sources.

Q: What if I'm already taking supplements like high-dose Vitamin C with Velorin 100?

Patients are generally advised to inform their healthcare provider about all medicines and supplements, including vitamins and herbal products. Official labels for similar medicines sometimes recommend separating doses of Velorin 100 from supplements containing minerals (like calcium or iron) by at least 2 hours to avoid reduced absorption.

Q: Is Velorin 100 similar to other drugs that treat the same condition?

Yes, Velorin 100 (Atenolol) belongs to the drug class known as beta-blockers. It is often compared to other medicines in this class and newer agents used for treating conditions like high blood pressure and angina (chest pain).

Q: Do I need to take Velorin 100 with food, or does it matter?

Official administration instructions generally state that this medicine is taken once daily. While some product guidance states it can be taken regardless of meals, other sources suggest taking it on an empty stomach to maintain consistent absorption.

Q: Why do doctors prescribe Velorin 100 over other options?

According to official documentation, the rationale for prescribing Velorin 100 is rooted in its pharmacological profile, specifically its property as a cardioselective beta-blocker. This characteristic means it primarily targets receptors in the heart, and its effectiveness is established to provide sustained reduction of heart rate and blood pressure over 24 hours with a single daily dose.

Q: Are there any long-term side effects associated with Velorin 100 use?

Regulatory labeling includes side effects observed during clinical trials. Official warnings note a risk of deterioration of heart failure over time and have identified potential effects on lipid (fat) metabolism. Monitoring by a healthcare provider may be necessary to identify any potential long-term changes.

Q: What happens if I accidentally miss a dose of Velorin 100?

Official guidance states that a missed dose may be taken as soon as it is remembered. However, if it is almost time for the next scheduled dose, the guidance is to skip the missed dose and continue with the regular schedule. Taking a double dose to compensate is not advised.

Q: What should I do if a side effect from Velorin 100 doesn't go away?

Patients are generally advised to contact their healthcare provider immediately if they experience any symptoms that are severe, or if side effects listed as serious in the official label are noticed. Consultation with a healthcare provider is suggested if less common side effects persist or are a concern.

Q: Is it possible to be allergic to Velorin 100?

Yes, official labeling lists a known hypersensitivity (allergy) to the active ingredient, Atenolol, as an absolute contraindication for use. Regulatory warnings also note that beta-blockers can potentially increase the severity of allergic reactions and interfere with the effectiveness of emergency treatments like epinephrine.

Q: Is it safe to suddenly stop taking Velorin 100?

Official regulatory warnings strongly advise against abruptly stopping Velorin 100 therapy, especially for patients with coronary artery disease. Sudden cessation can lead to serious risks, including the exacerbation of angina (chest pain) or a heart attack. A physician's supervision is required to implement a gradual withdrawal schedule.

Q: Why is my doctor starting me on Velorin 100 instead of a higher dose?

Official dosing guidelines typically recommend starting with the lowest effective dose to see how the patient's body responds to the medicine and to minimize initial side effects. Dosing is then gradually increased, or titrated, only after a specific period, such as one week, to ensure careful management.

Q: Is there a certain time of day that is best for taking Velorin 100?

While the medicine is generally taken once a day for chronic conditions, maintaining a consistent time of day is important for keeping drug levels steady. The specific time, such as morning or evening, is often determined with the input of a healthcare provider.

Q: Can Velorin 100 be taken during pregnancy?

Official warnings state that the medicine crosses the placenta and has been associated with risks, including the baby being born small-for-gestational-age if used during the second trimester. Use is restricted and is generally reserved for situations where a physician determines the potential maternal benefit outweighs the potential fetal risk.

Q: Is Velorin 100 safe while breastfeeding?

Regulatory information indicates that the drug is excreted into human milk. Because of the potential risk of adverse effects on the infant due to beta-blockade, such as a slow heart rate ( bradycardia), official guidance advises caution if this medicine is used during breastfeeding.

Q: Can Velorin 100 cause changes in appetite or weight?

Some official reports on beta-blockers, including Atenolol, have noted an association with weight gain, often occurring in the initial months of treatment. Changes in appetite, such as both loss of appetite and increased hunger, have also been reported as rare side effects.

Q: Does Velorin 100 lose its effectiveness over time?

Long-term clinical studies referenced in official documentation have not demonstrated a reduction in the blood pressure-lowering effect of the drug with continued, prolonged use.

Q: Is Velorin 100 a non-prescription drug in any country?

In the United States, Velorin 100 (Atenolol) is designated as a prescription-only medication. Due to its classification and intended use for chronic conditions, it requires a prescription from a licensed healthcare professional.

Q: Does stress affect how well Velorin 100 works?

Velorin 100 is designed to block beta-adrenergic receptors, which are the biological targets for stress hormones like adrenaline. By blocking these receptors, the medication modifies the body’s physical response to nervous system stimulation, including that caused by psychological stress, which helps manage heart rate and blood pressure.

Advertisements

How should Velorin 100 be stored and disposed of?

How to Store and Dispose of Velorin 100?

Velorin 100 (Atenolol tablets) must be stored at Controlled Room Temperature (CRT), maintaining a temperature range between 20°C and 25°C (68°F and 77°F). Brief temperature excursions are permitted between 15°C and 30°C (59°F and 86°F).

Environmental and Container Rules

The medication must be protected from moisture and kept in a tightly closed container to preserve its stability. Consistent with requirements for all prescription medicines, Velorin 100 must be stored out of the sight and reach of children.

Disposal of Unused Medicine

Disposal of unused or expired tablets should follow official guidance from government health authorities. The recommended procedure is to utilize a medicine take-back program or authorized collection site. If a collection program is unavailable, instructions are provided for discarding the medication in household trash with specific preparation to deter ingestion.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Velorin 100 found in:

A-Z Index: